Plasma hemopexin as a potential regulator of vascular responsiveness to angiotensin II

Reproductive Sciences

Volumn 20, Issue 3, 2013, Pages 234-237

  Bakker, Winston W ^a   Spaans, Floor ^a   El Bakkali, Loubna ^b   Borghuis, Theo ^a   Van Goor, Harry ^a   Van Dijk, Evert ^c   Buijnink, Joshua ^c   Faas, Marijke M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Pepscan Systems   (Netherlands)

Author keywords

angiotensin II receptor; ATP; hemopexin activity; protease like activity; vascular expansion

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA 2 MACROGLOBULIN; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANTITHROMBIN III; APYRASE; BENZYLSULFONYL FLUORIDE; BRADYKININ; CD39 ANTIGEN; CORTICOSTEROID; EDETIC ACID; HEMOPEXIN; PROTEINASE; SERINE PROTEINASE INHIBITOR; SOYBEAN TRYPSIN INHIBITOR;

BLOOD SAMPLING; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FROZEN SECTION; GESTATIONAL AGE; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; PROTEINURIA; RECEPTOR DOWN REGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANGIOTENSIN II; ANIMALS; FEMALE; HEMOPEXIN; HUMANS; MALE; PREGNANCY; PROTEIN BINDING; VASOCONSTRICTION; VASODILATION;

EID: 84874474124     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719112446081     Document Type: Review

References (27)

1. Grabar P, de Vaux St-Cyr C, Cleve H. Presence of β1-B globulin in the perchloric acid extracts of human normal serums. Bull Soc Chim Biol. 1960 ; 42: 853-856
2. Immenschuh S, Song DX, Satoh H, Muller-Eberhard U. The type II hemopexin interleukin-6 response element predominates the transcriptional regulation of the hemopexin acute phase responsiveness. Biochem Biophys Res Commun. 1995 ; 207 (1). 202-208
3. Morgan WT, Smith A. Binding and transport of iron-porphyrins by hemopexin. Adv Inorg Chem. 2001 ; 51: 205-241
4. Delanghe JR, Langois MR. Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin Chim Acta. 2001 ; 312 (1-2). 13-23 (Pubitemid 32913576)
5. Tolosano E, Fagonee S, Morello M, Vinchi F, Fiorito V. Heme scavenging and the other facets of hemopexin. Antioxid Redox Signal. 2010 ; 12 (2). 305-320
6. Marchot P, Chatonnet A. Enzymatic activity and protein interactions in alpha/beta hydrolase fold proteins: moonlighting versus promiscuity. Protein Pept Lett. 2012 ; 19 (2). 132-143
7. Sogorb MA, Diaz-Alejo N, Escudero MA, Vilanova E. Phosphotriesterase activity identified in purified serum albumins. Arch Toxicol. 1998 ; 72 (4). 219-226 (Pubitemid 28164017)
8. Suzuki K, Kato H, Sakuma Y, Namiki H. Hemopexins suppress phorbol ester-induced necrosis of polymorphonuclear leucocytes. Cell Struct Funct. 2001 ; 26 (4). 235-241 (Pubitemid 33048936)
9. Suzuki K, Kobayashi N, Doi T, Hijikata T, Machida I, Namiki H. Inhibition of Mg2+ dependent adhesion of polymorphonuclear leucocytes by serum hemopexin: differences in divalent-cation dependency of cell adhesion in the presence and absence of serum. Cell Struct Funct. 2003 ; 28 (4). 243-253 (Pubitemid 37406981)
10. Liang X, Lin T, Sun G, Beasley-Topliffe L, Cavaillon JM, Warren HS, Warren HS. Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages. J Leukoc Biol. 2009 ; 86 (2). 229-235
11. Cheung PK, Stulp B, Immenschuh S, Borghuis T, Baller JF, Bakker WW. Is 100KF an isoform of hemopexin? Immunochemical characterization of the vasoactive plasma factor 100KF. J Am Soc Nephrol. 1999 ; 10 (8). 1700-1708 (Pubitemid 29364668)
12. Bakker WW, Borghuis T, Harmsen MC, et al. Protease activity of plasma hemopexin. Kidney Int. 2005 ; 68 (2). 603-610 (Pubitemid 43323115)
13. Mangan MS, Kaiseman D, Bird PI. The role of serpins in vertebrate immunity. Tissue Antigens. 2008 ; 72 (1). 1-10 (Pubitemid 351841645)
14. Colman RW. Contact activation pathway: inflammatory, fibrinolytic, anticoagulant, anti-adhesive and anti-angiogenic activities. In: Coman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Hemostasis and Thrombosis; Basic Principles and Clinical Practice. 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:103-121.
15. Bakker WW, Henning RH, van Son WJ, et al. Vascular contraction and preeclampsia: down-regulation of the angiotensin receptor 1 by hemopexin in vitro. Hypertension. 2009 ; 53 (6). 959-964
16. Bakker WW, Donker RB, Timmer A, et al. Plasma hemopexin activity in pregnancy and preeclampsia. Hypertens Pregnancy. 2007 ; 26 (2). 227-239 (Pubitemid 46676548)
17. Spiller F, Costa C, Souto FO, et al. Inhibition of neutrophil migration by hemopexin leads to increased mortality due to sepsis in mice. Am J Respir Crit Care Med. 2011 ; 183 (7). 922-931
18. Grant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973 ; 52 (11). 2682-2689
19. Mitchell RN, Schoen J. Blood vessels. In: Kumar V, Abbas AK, Fausto N, Aster JC, eds. The Pathologic Basis of Diseases. Philadelphia, Pa: Saunders Elsevier; 2010:487-529.
20. Cheung PK, Klok PA, Bakker WW. Minimal change-like glomerular alterations induced by a human plasma factor. Nephron. 1996 ; 74 (3). 586-593 (Pubitemid 26364733)
21. Bakker WW, van Dael CM, Pierik LJ, et al. Altered activity of plasma hemopexin in patients with minimal change disease in relapse. Pediatr Nephrol. 2005 ; 20 (10). 1410-1415 (Pubitemid 41403414)
22. Cheung PK, Klok PA, Baller JF, Bakker WW. Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin. Kidney Int. 2000 ; 57 (4). 1512-1520 (Pubitemid 30207910)
23. Kapojos JJ, Poelstra K, Borghuis T, Banas B, Bakker WW. Regulation of plasma hemopexin activity by stimulated endothelial or mesangial cells. Nephron Physiol. 2004 ; 96 (1). 1-10
24. Mauk MR, Smith A, Mauk AG. An alternative view of the proposed alternative activities of hemopexin. Protein Sci. 2011 ; 20 (5). 791-805
25. Dunker AK, Kriwacki RW. The orderly chaos of proteins. Sci Am. 2011 ; 304 (4). 68-73
26. Chouard T. Breaking the protein rules. Nature. 2011 ; 471 (7337). 151-153
27. Wang Y, Fisher JC, Mathew R, et al. Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21. Nat Chem Biol. 2011 ; 7 (4). 214-221